IMV Inc. to Present at Upcoming Investor Conferences
May 14 2019 - 4:05PM
Business Wire
IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical stage
immuno-oncology company today announced that IMV Chief Executive
Officer Frederic Ors will present at the following investor
conferences in May:
RBC Capital Markets Global Healthcare Conference
- Date: Tuesday, May 21, 2019
- Time: 1:35 p.m. ET
- Location: The InterContinental
New York Barclay Hotel, New York, NY
National Bank Financials’ 9th Annual Quebec
Conference
- Date: Wednesday, May 29,
2019
- Time: 9:50 a.m. ET
- Location: Museum Room,
Shangri-la Hotel, Toronto, Ontario
China Bio-Partnering Forum
- Date: Thursday, May 30,
2019
- Time: 1:40 p.m. CT
- Location: Renaissance Schaumburg
Convention Center Hotel, Chicago, IL
A copy of each meeting’s presentation will be available in the
events and presentations section of IMV’s website. A live webcast
of IMV’s presentation at the RBC Capital Markets conference will
also be available and archived for 90 days on the events and
presentations webpage.
About IMV
IMV Inc. is a clinical stage biopharmaceutical company dedicated
to making immunotherapy more effective, more broadly applicable,
and more widely available to people facing cancer and other serious
diseases. IMV is pioneering a new class of immunotherapies based on
the Company’s proprietary drug delivery platform. This patented
technology leverages a novel mechanism of action that enables the
programming of immune cells in vivo, which are aimed at
generating powerful new synthetic therapeutic capabilities. IMV’s
lead candidate, DPX-Survivac, is a T cell-activating immunotherapy
that combines the utility of the platform with a target: survivin.
IMV is currently assessing DPX-Survivac as a monotherapy in
advanced ovarian cancer, as well as a combination therapy in
multiple clinical studies with Merck. Connect
at www.imv-inc.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190514005899/en/
Investor Relations:Marc Jasmin, IMV Senior Director,
Investor Relations and CommunicationsO: (902) 492-1819 ext : 1042M:
(514) 617-9481 E: mjasmin@imv-inc.com
Media:Andrea Cohen, Sam Brown Inc.T: (917) 209-7163
E: andreacohen@sambrown.com
IMV (TSX:IMV)
Historical Stock Chart
From Jun 2024 to Jul 2024
IMV (TSX:IMV)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about IMV Inc (Toronto Stock Exchange): 0 recent articles
More Imv News Articles